Sanofi-Aventis to Acquire Merck's Interest in Merial
GLOBAL - Sanofi-Aventis and Merck & Co., Inc. today announced that the companies have signed a definitive agreement under which Merck will sell its 50 per cent interest in the companies' current animal health joint venture, Merial Limited (Merial), to Sanofi-Aventis for $4 billion (US) in cash.
30 July 2009
2 minute read
